Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL
出版年份 2021 全文链接
标题
Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL
作者
关键词
-
出版物
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-25
DOI
10.1038/s41418-020-00692-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Changes in Bcl-2 members in response to ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL
- (2020) Marco Vincent Haselager et al. BLOOD
- NIK–IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation
- (2019) Paulina Kucharzewska et al. JOURNAL OF CELL SCIENCE
- Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
- (2019) Kirsten Fischer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2018) John F. Seymour et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
- (2018) Andrew Paul et al. Cells
- Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers
- (2017) Nahoum G. Anthony et al. JOURNAL OF MEDICINAL CHEMISTRY
- Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia
- (2017) M H A van Attekum et al. ONCOGENE
- High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
- (2016) Sina Oppermann et al. BLOOD
- NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions
- (2016) Larry Mansouri et al. SEMINARS IN CANCER BIOLOGY
- Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+lymphoid malignancies
- (2015) Andrew W. Roberts et al. BRITISH JOURNAL OF HAEMATOLOGY
- Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study
- (2015) Anthony W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
- (2015) Larry Mansouri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles
- (2015) Anthony Mathelier et al. NUCLEIC ACIDS RESEARCH
- Noncanonical NF- B Signaling Is Limited by Classical NF- B Activity
- (2014) C. M. Gray et al. Science Signaling
- Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity
- (2014) Katharina L. Willmann et al. Nature Communications
- Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure–activity relationship, and co-crystal structures
- (2013) Kexue Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- NIK Controls Classical and Alternative NF- B Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells
- (2013) L. Odqvist et al. CLINICAL CANCER RESEARCH
- APPL1 regulates basal NF-κB activity by stabilizing NIK
- (2012) Anna Hupalowska et al. JOURNAL OF CELL SCIENCE
- c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells
- (2011) J. C. Allen et al. BLOOD
- Non-canonical NF-κB signaling activation and regulation: principles and perspectives
- (2011) Bahram Razani et al. IMMUNOLOGICAL REVIEWS
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF- B Activation and De novo Gene Transcription
- (2010) A. G. S. Buggins et al. CANCER RESEARCH
- Dichotomy in NF-κB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering
- (2010) J M Tromp et al. ONCOGENE
- Regulation and Function of NF-κB Transcription Factors in the Immune System
- (2009) Sivakumar Vallabhapurapu et al. Annual Review of Immunology
- The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions
- (2009) J. A. Burger et al. BLOOD
- Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
- (2009) A. V. Kurtova et al. BLOOD
- c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches
- (2008) D. Y. H. Hallaert et al. BLOOD
- Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
- (2008) M. Vogler et al. BLOOD
- Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling
- (2008) Sivakumar Vallabhapurapu et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search